Provider
P63-16 Drug Related Prior Authorization Criteria Changes for Ampyra, H.P. Acthar Gel, Transmucosal Fentanyl, Growth Hormone, and Oral Pulmonary Arterial Hypertension Agents
Program effective Date: Dec 20, 2016
Search Results
Displaying 3231 - 3240 of 3690 results
Provider
P31-17 New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Thrombopoietin Receptor Agents
Program effective Date: Jun 05, 2017
Provider
P60-16 New Drug-Related Prior Authorization Criteria with Quanatity Limit for Topical Diclofenac Gel, Fluorourcil Cream, Imquimod Cream and Ingenol Gel
Program effective Date: Dec 13, 2016
Provider
P39-16 Expansion of Drug-Related Xenazine Prior Authorization Criteria with Quantity Limit to Minnesota Health Care Programs
Program effective Date: Aug 03, 2016
Provider
P40-16 New Drug-Related Prior Authorization Criteria with Quantity Limit for Lidocaine Transdermal
Program effective Date: Aug 03, 2016
Provider
P44-16 Addition of a Drug (Viekira XR) to the Hepatitis C Second Generation Prior Authorization with Quantity Limit Program
Program effective Date: Sep 01, 2016
Provider
P47-17 Change to the Requirement to Submit National Drug Codes
Program effective Date: Aug 23, 2017
Provider
P36-16 Case Management (T1016) Billing for Tuberculosis Related Services for Government Programs Subscribers
Program effective Date: Jul 27, 2016
Provider
P41-16 Live Attenuated Influenza Vaccine (LAIV) Will Not Be Covered During the 2016-2017 Flu Season
Program effective Date: Aug 03, 2016
Provider
P10-17 Changes in Medical Policy IV-122 Knee Arthroplasty (Knee Replacement)
Program effective Date: Mar 24, 2017